We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment.
- Authors
Kyung-Soo Kim; Byung-Wan Lee; Yong Jin Kim; Dae Ho Lee; Bong-Soo Cha; Cheol-Young Park
- Abstract
Nonalcoholic fatty liver disease (NAFLD) and diabetes are common metabolic disorders that are often comorbid conditions. Among many proposed treatments, weight reduction is the only approved option for NAFLD to date. However, it is not easy to maintain weight loss by lifestyle modification alone; pharmacological treatments are helpful in this regard. Although many drugs have been investigated, pioglitazone could be a first-line therapy in patients with NAFLD and diabetes. Many more drugs are currently being developed and investigated, and it is likely that combination strategies will be used for future treatment of NAFLD and diabetes. Attention should be paid to the management of NAFLD and diabetes and efforts should be made to intervene early and individualize treatment of NAFLD in patients with diabetes.
- Subjects
FATTY liver; THERAPEUTICS; WEIGHT loss; DIABETES; METABOLIC disorders
- Publication
Diabetes & Metabolism Journal, 2019, Vol 43, Issue 2, p127
- ISSN
2233-6079
- Publication type
Article
- DOI
10.4093/dmj.2019.0034